Self-help mobile messaging intervention for depression among older adults in resource-limited settings: a randomized controlled trial
Scalable solutions to treat depression in older adults in low-resourced settings are urgently needed. The PRODIGITAL-D pragmatic, single-blind, two-arm, individually randomized controlled trial assessed the effectiveness of a mobile messaging psychosocial intervention in improving depressive symptomatology among older adults in socioeconomically deprived areas of Guarulhos, Brazil. Older adults (aged 60+ years) registered with 24 primary care clinics and identifed with depressive symptomatology (9-item Patient Health Questionnaire (PHQ-9) scores ≥ 10) received the 6-week Viva Vida intervention based on psychoeducation and behavioral activation (n = 298) or a single message (n = 305). No health professional support was ofered. The primary outcome was improvement from depressive symptomatology (PHQ-9 < 10) at 3 months. Of the 603 participants enrolled (mean age = 65.1 years; 451 (74.8%) women), 527 (87.4%) completed the follow-up assessment. In the intervention arm, 109 of 257 (42.4%) participants had an improved depressive symptomatology, compared with 87 of 270 (32.2%) participants in the control arm (adjusted odds ratio = 1.57; 95% confdence interval = 1.07–2.29; P = 0.019). No severe adverse events related to trial participation were observed. These results demonstrate the usefulness of a digital messaging psychosocial intervention in the short-term improvement from depressive symptomatology that can potentially be integrated into primary care programs for treating older adults with depression. Brazilian Registry of Clinical Trials registration: ReBEC (RBR-4c94dtn).
History
Publication
nature medicinePublisher
Nature PortfolioOther Funding information
São Paulo Research Foundation (process no. 2017/50094-2, awarded to M.S.) and the Joint Global Health Trials initiative, jointly funded by the Department of Health and Social Care, the Foreign, Commonwealth & Development Office, the Medical Research Council and Wellcome (process no. MR/R006229/1, awarded to R.A., T.J.P. and W.H.). We were supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico-Brazil (no. 307579/2019-0, M.S.) and Fundação de Amparo à Pesquisa do Estado de São Paulo (nos. 2018/19343-9 and 2022/05107-7 to C.A.N.; no. 2021/04493-8 to T.V.N.D.; no. 2020/02272-1, F.A.M.; no. 2020/14768-1 to M.O.d.C.; no. 2020/14504-4 to C.H.Q.d.S.; no. 2021/04230-7 to G.M.d.O.; nos. 2021/10148-1 and 2022/08668-0 to M.S.d.S.; and no. 2021/03849-3 to M.M.d.S.M.)Also affiliated with
- Health Research Institute (HRI)
Sustainable development goals
- (3) Good Health and Well-being
- (17) Partnerships for the Goals
External identifier
Department or School
- Electronic & Computer Engineering